FibroGen's market cap is currently $41.98M. The company's EPS TTM is $-1.88; its P/E ratio is ―; FibroGen is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-4.00. See an overview of income statement, balance sheet, and cash flow financials.
